Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 36; no. 7; p. e106
Main Author Home, Philip D
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.07.2013
Subjects
Diabetes Mellitus, Type 2 - drug therapy
Female
Humans
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - therapeutic use
Insulin - therapeutic use
Insulin, Long-Acting - therapeutic use
Male
Online Letters: Comments and Responses
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0149-5992
1935-5548
DOI:10.2337/dc13-0038